Prognostic value of baseline (18)F-FDG PET/CT metabolic parameters in EGFR-mutant lung adenocarcinoma patients treated with EGFR-TKIs.

Wang L, Wang Z, Wu W

Open source

DOI
10.3389/fnume.2026.1864776
Published
2026
Container
Frontiers in nuclear medicine
Publisher
Not recorded
Open access
yes

Credibility signals

uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3389/fnume.2026.1864776,
  title = {Prognostic value of baseline (18)F-FDG PET/CT metabolic parameters in EGFR-mutant lung adenocarcinoma patients treated with EGFR-TKIs.},
  author = {Wang L and Wang Z and Wu W},
  year = {2026},
  journal = {Frontiers in nuclear medicine},
  doi = {10.3389/fnume.2026.1864776},
  url = {https://doi.org/10.3389/fnume.2026.1864776}
}

RIS

TY  - JOUR
TI  - Prognostic value of baseline (18)F-FDG PET/CT metabolic parameters in EGFR-mutant lung adenocarcinoma patients treated with EGFR-TKIs.
AU  - Wang L
AU  - Wang Z
AU  - Wu W
PY  - 2026
JO  - Frontiers in nuclear medicine
DO  - 10.3389/fnume.2026.1864776
UR  - https://doi.org/10.3389/fnume.2026.1864776
ER  - 

APA

L, W., Z, W., & W, W. (2026). Prognostic value of baseline (18)F-FDG PET/CT metabolic parameters in EGFR-mutant lung adenocarcinoma patients treated with EGFR-TKIs.. Frontiers in nuclear medicine. https://doi.org/10.3389/fnume.2026.1864776

Source records